Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Loss	$ (117,688)	$ (29,655)	$ (74,286)
Depreciation and amortization	219,512	228,774	235,151
Amortization of Inventory Step-up	0	0	26,519
Operating Lease, Right-of-Use Asset, Amortization Expense	21,344	21,910	23,651
Provision for doubtful accounts	5,800	838	1,036
Provision for warranty and returns	1,130	21,582	4,902
Stock compensation	46,883	40,563	36,025
Loss on Disposition of Property Plant Equipment, net	2,522	2,109	2,010
Debt issuance cost amortization	6,807	6,814	6,972
Change in fair value of contingent earn-out	(5,399)	(16,247)	(32,091)
Sparepartsusage	18,298	17,050	11,924
Other	7,393	8,066	(213)
Increase (Decrease) in Accounts Receivable	(46,844)	48,635	(19,151)
Increase (Decrease) in Inventories	16,829	(6,079)	(201,095)
Increase (Decrease) in Prepaid Expense and Other Assets	(8,829)	11,672	22,903
Increase (Decrease) in Other Operating Assets	(23,154)	(24,695)	(21,290)
Accounts payable	12,531	(68,301)	37,472
Accrued liabilities	20,668	(14,479)	(55,834)
Income taxes, including excess tax benefits and deferred income taxes	26,230	(82,356)	(66,734)
Net cash provided by (used in)operating activities	204,033	166,201	(62,129)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, plant and equipment	(79,373)	(83,893)	(90,311)
Proceeds from sale of assets	746	1,501	989
Intangible asset additions	(10,833)	(9,777)	(9,018)
Business acquisitions, net of cash acquired	0	0	(1,844,164)
Purchases of investment securities	0	0	(3,397)
Proceeds from sale of investment securities	500	4,222	36,433
Net cash used in by investing activities	(88,960)	(87,947)	(1,909,468)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of long-term debt, net of lender debt issuance costs	0	0	1,664,362
Repayments of Long-term obligations	(51,000)	(29,688)	(22,375)
Payments of Debt Issuance Costs	0	0	(2,177)
Proceeds from exercise of stock options	10,939	4,022	8,785
Payments on finance leases	(1,147)	(963)	(680)
Payment for Contingent Consideration Liability, Financing Activities	(2,600)	0	0
Purchase of treasury stock	(11,992)	(9,350)	(10,883)
Net cash (used in) provided by financing activities	(55,800)	(35,979)	1,637,032
Effect of Exchange Rate on Cash [Abstract]
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	(4,929)	3,163	(9,478)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total	54,344	45,438	(344,043)
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents	308,566	254,222	208,784
SUPPLEMENTAL DISCLSOURE OF CASH FLOW INFORMATION
Cash paid during the year for income taxes	25,253	35,809	27,504
Interest Paid, Excluding Capitalized Interest, Operating Activities	99,717	95,913	63,713
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING ACTIVITIES
Accounts payable for property, plant and equipment	$ 7,443	$ 6,570	4,854
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable			(575,975)
Foreign Infusion System Supplier
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING ACTIVITIES
Fair value of assets acquired			1,606,300
Cash paid for acquisitions, net of cash acquired			(1,844,164)
Contingent consideration			(55,158)
Goodwill, Period Increase (Decrease)			1,462,752
Liabilities Assumed			$ 593,755